About Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
Clinical Trials at Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
During the past decade, Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
According to Clinical.Site data, the most researched conditions in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi" are
"Idiopathic Pulmonary Fibrosis" (2 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi" in a lesser frequency.
Clinical Trials Intervention Types at Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
Most popular intervention types in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
The vast majority of trials in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi" are
3 trials for "All" genders.
Clinical Trials Status at Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi
Currently, there are NaN active trials in "Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".